CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 152 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $17,818,000 | +423.0% | 1,136,367 | +251.5% | 0.05% | +440.0% |
Q3 2015 | $3,407,000 | -92.3% | 323,274 | -81.6% | 0.01% | -91.5% |
Q2 2015 | $44,196,000 | -31.9% | 1,752,424 | -24.7% | 0.12% | -28.7% |
Q1 2015 | $64,854,000 | +33.1% | 2,327,028 | -12.8% | 0.16% | +32.3% |
Q4 2014 | $48,724,000 | +139.9% | 2,669,796 | +70.4% | 0.12% | +143.1% |
Q3 2014 | $20,311,000 | -63.1% | 1,567,233 | -53.6% | 0.05% | -19.0% |
Q2 2014 | $55,078,000 | +566.1% | 3,374,928 | +621.2% | 0.06% | +231.6% |
Q1 2014 | $8,269,000 | -66.3% | 467,952 | -53.8% | 0.02% | -65.5% |
Q4 2013 | $24,539,000 | -54.8% | 1,013,570 | -33.9% | 0.06% | -56.0% |
Q3 2013 | $54,306,000 | +88.3% | 1,532,763 | -17.0% | 0.12% | +86.6% |
Q2 2013 | $28,841,000 | – | 1,847,569 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TSP Capital Management Group, LLC | 844,981 | $15,421,000 | 7.11% |
DOHENY ASSET MANAGEMENT /CA | 195,345 | $3,565,000 | 1.70% |
First Light Asset Management, LLC | 153,617 | $2,804,000 | 1.59% |
Rhenman & Partners Asset Management AB | 175,000 | $3,194,000 | 0.93% |
Iguana Healthcare Management, LLC | 100,000 | $1,825,000 | 0.88% |
Eventide Asset Management | 288,700 | $5,269,000 | 0.58% |
Bedell Frazier Investment Counselling, LLC | 60,820 | $1,110,000 | 0.54% |
STONERIDGE INVESTMENT PARTNERS LLC | 214,327 | $3,911,000 | 0.52% |
Fernwood Investment Management, LLC | 31,350 | $572,000 | 0.49% |
SUFFOLK CAPITAL MANAGEMENT LLC | 168,560 | $3,076,000 | 0.37% |